Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Olympia
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Olympia, WA

Studies commonly pay $75 to $4,500 per completed study

225 clinical trials are currently recruiting participants within 30 miles of Olympia. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

225studies recruiting
5+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Olympia right now

Top 25 of 225 recruiting studies, sorted by proximity — each links to its official registry page

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation N/A Observational 20,000 participants sought
MultiCare Institute for Research & Innovation — Tacoma, Washington (25.8 mi) · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,900 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer Phase 3 Interventional 400 participants sought
Providence Regional Cancer System - Lacey — Lacey, Washington (3.5 mi) · Sponsor: Pfizer

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Northwest Medical Specialties, PLLC ( Site 0067) — Tacoma, Washington (25.8 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
MultiCare Health System — Tacoma, Washington (25.8 mi) · Sponsor: Eli Lilly and Company

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Triple Negative Breast Cancer Phase 3 Interventional 1,514 participants sought
Providence Regional Cancer System — Lacey, Washington (3.5 mi) · Sponsor: Gilead Sciences

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Multicare Health System — Tacoma, Washington (25.8 mi) · Sponsor: Novo Nordisk A/S

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: NRG Oncology

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: NRG Oncology

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Saint Clare Hospital — Lakewood, Washington (19.9 mi) · Sponsor: NRG Oncology

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
MultiCare Institute for Research & Innovation /ID# 255954 — Tacoma, Washington (25.8 mi) · Sponsor: AbbVie

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Obesity, Heart Failure Phase 3 Interventional 5,610 participants sought
CHI Franciscan Research Center — Tacoma, Washington (25.8 mi) · Sponsor: Novo Nordisk A/S

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought
Northwest Medical Specialties Tacoma /ID# 276281 — Tacoma, Washington (25.8 mi) · Sponsor: AbbVie

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis, Crohn's Disease Phase 3 Interventional 70 participants sought
Multicare Health System Institute for Research and Innovation — Tacoma, Washington (25.8 mi) · Sponsor: Takeda

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Locally Advanced Breast Cancer Phase 3 Interventional 1,000 participants sought
Clinical Trial Site — Olympia, Washington (0.4 mi) · Sponsor: Olema Pharmaceuticals, Inc.

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Tacoma, Washington (25.8 mi) · Sponsor: Hoffmann-La Roche

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: SWOG Cancer Research Network

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Northwest Medical Specialties — Tacoma, Washington (25.8 mi) · Sponsor: Hoffmann-La Roche

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
American Oncology Network Vista Oncology Division-West office — Olympia, Washington (0.4 mi) · Sponsor: Pfizer
Actively enrolling

Studies you may be able to join near Olympia

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Olympia

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Vantage Clinical Research Group

3703 Ensign Rd NE #10A, Olympia, WA 98506
(360) 459-5515

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Providence Regional Cancer System - Lacey

★ 4.4 (23 reviews)
4525 3rd Ave SE #200, Lacey, WA 98503
(360) 754-3934
"Would be a 5, but all the healthy workers taking ALL the parking spots surrounding the handicap spots. There are more than 10 handicapped patients th…"
— Fraser Mack, 3★

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Clinical trials in Olympia: what's recruiting

The Olympia area currently has 225 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Olympia, the most active research areas are:

  • Cancer & Oncology16 studies
  • Liver & Kidney2 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Olympia, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Olympia

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Olympia participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Olympia pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Olympia, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Olympia?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Olympia?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Olympia.

Paid clinical trials near Olympia

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of WA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts